MODIFICATION
B -- FO Elucidating the Association of Oral Transmucosal Pain Reduction Drugs and Dental Adverse Events Using Integrated Real-World Data Sources
- Notice Date
- 8/1/2022 11:25:12 AM
- Notice Type
- Solicitation
- NAICS
- 541611
— Administrative Management and General Management Consulting Services
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- FO1256636
- Response Due
- 8/9/2022 7:00:00 AM
- Archive Date
- 08/24/2022
- Point of Contact
- Telisha WIlson
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Description
- Elucidating the Association of Oral Transmucosal Pain Reduction Drugs and Dental Adverse Events Using Integrated Real-World Data Sources
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/d59362ee1bac42dd821deee425c9309a/view)
- Record
- SN06408562-F 20220803/220801230125 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |